BHST
BioHarvest Sciences Inc. Common Stock
Price Chart
Latest Quote
$3.28
-0.03 (-0.91%)
Current Price
| Previous Close | $3.31 |
| Open | $3.38 |
| Day High | $3.38 |
| Day Low | $3.26 |
| Volume | 8,398 |
Stock Information
| Shares Outstanding | 22.67M |
| Total Debt | $14.04M |
| Cash Equivalents | $20.17M |
| Revenue | $35.16M |
| Net Income | $-11.44M |
| Sector | Consumer Defensive |
| Industry | Packaged Foods |
| Market Cap | $74.35M |
| EPS (TTM) | $-0.58 |
| Exchange | NGM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $68.90M |
| Sales | $35.16M |
| Income | $-11.44M |
| Book/sh | $1.12 |
| Cash/sh | $0.89 |
| Employees | 89 |
Financial Ratios
| Quick Ratio | 2.44 |
| Current Ratio | 2.96 |
| Debt/Eq | 60.98 |
Returns & Margins
| ROA | -9.86% |
| ROE | -103.29% |
| Gross Margin | 59.50% |
| Operating Margin | -21.56% |
| Profit Margin | -32.54% |
Ownership
| Insider Ownership | 14.77% |
| Institutional Ownership | 7.51% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -19.88 |
| P/S | 2.11 |
| P/B | 2.92 |
Analyst Data
| Recommendation | none |
| Target Price | $12.75 |
Technical Indicators
| SMA20 | $3.50 |
| SMA50 | $3.92 |
| SMA200 | $5.99 |
| RSI | 26.87 |
| ATR | 0.1972 |
| Shares Float | 17.82M |
| Short Float | 0.37% |
| Short Ratio | 1.81 |
| Rel Volume | 0.38 |
Performance History
| Week | +6.15% |
| Month | -17.17% |
| Quarter | -24.77% |
| 6 Months | -36.92% |
| YTD | -37.04% |
| Year | -52.05% |
| 3 Years | -44.87% |
| 5 Years | -62.96% |
| 10 Years | -67.68% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-17 | $3.28 | 8,500 |
| 2026-06-16 | $3.31 | 23,200 |
| 2026-06-15 | $3.38 | 13,300 |
| 2026-06-12 | $3.20 | 15,200 |
| 2026-06-11 | $3.20 | 8,400 |
| 2026-06-10 | $3.09 | 28,800 |
| 2026-06-09 | $3.02 | 16,700 |
| 2026-06-08 | $3.12 | 14,200 |
| 2026-06-05 | $3.19 | 64,300 |
| 2026-06-04 | $3.25 | 67,600 |
| 2026-06-03 | $3.56 | 27,300 |
| 2026-06-02 | $3.62 | 16,000 |
| 2026-06-01 | $3.70 | 14,200 |
| 2026-05-29 | $3.86 | 20,400 |
| 2026-05-28 | $3.90 | 27,600 |
| 2026-05-27 | $3.92 | 26,200 |
| 2026-05-26 | $3.91 | 31,400 |
| 2026-05-22 | $3.86 | 9,900 |
| 2026-05-21 | $3.82 | 2,900 |
| 2026-05-20 | $3.72 | 12,700 |
| 2026-05-19 | $3.92 | 14,500 |
| 2026-05-18 | $3.96 | 62,500 |
About BioHarvest Sciences Inc. Common Stock
BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through two segments: Products and CDMO Services. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science-based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional food and beverages, as well as the manufacturing, marketing, and sale of science-based health, pharmaceutical, and cosmeceutical solutions. The company also provides contract development and manufacturing operation services. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red wine. The company has a strategic collaboration with Tate & Lyle plc for the development of plant-based sweetener molecules. The company is based in Vancouver, Canada.
đ° Latest News
BioHarvest Sciences and Tate & Lyle expand sweetener development program
Proactive âĸ 2026-05-19T12:39:00Z
BioHarvest (BHST) Q1 2026 Earnings Transcript
Motley Fool âĸ 2026-05-18T13:08:45Z
BioHarvest Sciences Inc. Common Stock Q1 2026 Earnings Call Summary
Moby âĸ 2026-05-15T12:30:00Z
BioHarvest Sciences Inc (BHST) Q1 2026 Earnings Call Highlights: Revenue Growth and Strategic ...
GuruFocus.com âĸ 2026-05-14T23:03:09ZBioHarvest Sciences Q1 Earnings Call Highlights
MarketBeat âĸ 2026-05-14T14:07:39Z
BioHarvest Sciences Q1 revenue climbs as it expands botanical synthesis pipeline
Proactive âĸ 2026-05-14T12:39:00Z
BioHarvest Sciences Inc. (BHST) Reports Q1 Loss, Beats Revenue Estimates
Zacks âĸ 2026-05-14T11:10:01Z
Bionano Genomics, Inc. (BNGO) Reports Q1 Loss, Tops Revenue Estimates
Zacks âĸ 2026-05-13T21:35:02Z
BioHarvest Sciences advances synthetic saffron program with SaffronTech partnership
Proactive âĸ 2026-05-13T13:48:00Z
BioHarvest Sciences wins $1.2M fragrance contract
Proactive âĸ 2026-05-12T13:02:00Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $12,850,000 | $10,394,000 | $6,353,000 | $3,738,000 |
| Cost Of Revenue | $14,032,000 | $11,246,000 | $7,039,000 | $4,279,000 |
| Total Revenue | $34,508,000 | $25,188,000 | $12,672,000 | $5,498,000 |
| Operating Revenue | $34,508,000 | $25,188,000 | $12,672,000 | $5,498,000 |
| Expenses | ||||
| Interest Expense | $2,723,000 | $4,738,000 | $1,962,000 | $1,399,000 |
| Total Expenses | $40,083,000 | $32,177,000 | $22,638,000 | $16,110,000 |
| Other Income Expense | $-1,830,000 | $-483,000 | $-500,000 | $861,000 |
| Net Non Operating Interest Income Expense | $-3,654,000 | $-5,433,000 | $-2,098,000 | $-1,485,000 |
| Total Other Finance Cost | $985,000 | $695,000 | $136,000 | $86,000 |
| Interest Expense Non Operating | $2,723,000 | $4,738,000 | $1,962,000 | $1,399,000 |
| Operating Expense | $26,051,000 | $20,931,000 | $15,599,000 | $11,831,000 |
| Other Operating Expenses | $1,155,000 | $1,066,000 | - | - |
| Selling And Marketing Expense | $13,210,000 | $9,262,000 | $6,396,000 | $4,302,000 |
| General And Administrative Expense | $5,932,000 | $5,407,000 | $5,680,000 | $5,050,000 |
| Rent Expense Supplemental | - | $27,000 | $26,000 | $39,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-11,135,000 | $-12,913,000 | $-12,564,000 | $-11,236,000 |
| Net Interest Income | $-3,654,000 | $-5,433,000 | $-2,098,000 | $-1,485,000 |
| Interest Income | $54,000 | $0 | - | - |
| Normalized Income | $-9,689,300 | $-12,531,430 | $-12,064,000 | $-12,097,000 |
| Net Income From Continuing And Discontinued Operation | $-11,135,000 | $-12,913,000 | $-12,564,000 | $-11,236,000 |
| Total Operating Income As Reported | $-5,575,000 | $-6,989,000 | $-9,966,000 | $-10,612,000 |
| Net Income Common Stockholders | $-11,135,000 | $-12,913,000 | $-12,564,000 | $-11,236,000 |
| Net Income | $-11,135,000 | $-12,913,000 | $-12,564,000 | $-11,236,000 |
| Net Income Including Noncontrolling Interests | $-11,135,000 | $-12,913,000 | $-12,564,000 | $-11,236,000 |
| Net Income Continuous Operations | $-11,135,000 | $-12,913,000 | $-12,564,000 | $-11,236,000 |
| Pretax Income | $-11,059,000 | $-12,905,000 | $-12,564,000 | $-11,236,000 |
| Interest Income Non Operating | $54,000 | $0 | - | - |
| Operating Income | $-5,575,000 | $-6,989,000 | $-9,966,000 | $-10,612,000 |
| Depreciation Amortization Depletion Income Statement | $442,000 | $399,000 | $154,000 | $171,000 |
| Depreciation And Amortization In Income Statement | $442,000 | $399,000 | $154,000 | $171,000 |
| Gross Profit | $20,476,000 | $13,942,000 | $5,633,000 | $1,219,000 |
| Depreciation Income Statement | - | - | $156,000 | $171,000 |
| Per Share | ||||
| Diluted EPS | $-0.60 | $-0.80 | $-0.93 | $-0.70 |
| Basic EPS | $-0.60 | $-0.80 | $-0.93 | $-0.70 |
| Other | ||||
| Tax Effect Of Unusual Items | $-384,300 | $-101,430 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-4,882,000 | $-6,433,000 | $-9,262,000 | $-9,986,000 |
| Total Unusual Items | $-1,830,000 | $-483,000 | $-500,000 | $861,000 |
| Total Unusual Items Excluding Goodwill | $-1,830,000 | $-483,000 | $-500,000 | $861,000 |
| Reconciled Depreciation | $1,624,000 | $1,251,000 | $840,000 | $712,000 |
| EBITDA (Bullshit earnings) | $-6,712,000 | $-6,916,000 | $-9,762,000 | $-9,125,000 |
| EBIT | $-8,336,000 | $-8,167,000 | $-10,602,000 | $-9,837,000 |
| Diluted Average Shares | $18,411,153 | $16,193,787 | $13,533,160 | $13,053,644 |
| Basic Average Shares | $18,411,153 | $16,193,787 | $13,533,160 | $13,053,644 |
| Diluted NI Availto Com Stockholders | $-11,135,000 | $-12,913,000 | $-12,564,000 | $-11,236,000 |
| Tax Provision | $76,000 | $8,000 | $0 | - |
| Gain On Sale Of Security | $-1,830,000 | $-483,000 | $-500,000 | $861,000 |
| Research And Development | $5,312,000 | $4,797,000 | $3,369,000 | $2,308,000 |
| Selling General And Administration | $19,142,000 | $14,669,000 | $12,076,000 | $9,352,000 |
| Other Gand A | $975,000 | $1,404,000 | $2,135,000 | $1,509,000 |
| Salaries And Wages | $4,957,000 | $4,003,000 | $3,519,000 | $3,502,000 |
| Rent And Landing Fees | - | $27,000 | $26,000 | $39,000 |
Fetched: 2026-06-16
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $25,448,000 | $1,330,000 | $-14,853,000 | $-5,929,000 |
| Total Assets | $47,665,000 | $25,001,000 | $15,002,000 | $9,393,000 |
| Total Non Current Assets | $17,165,000 | $17,145,000 | $5,950,000 | $5,071,000 |
| Other Non Current Assets | $433,000 | $371,000 | $179,000 | $163,000 |
| Current Assets | $30,500,000 | $7,856,000 | $9,052,000 | $4,322,000 |
| Prepaid Assets | $673,000 | $469,000 | $263,000 | $486,000 |
| Inventory | $4,559,000 | $3,655,000 | $2,466,000 | $1,378,000 |
| Receivables | $2,243,000 | $1,342,000 | $968,000 | $722,000 |
| Other Receivables | $262,000 | $226,000 | $160,000 | $177,000 |
| Accounts Receivable | $1,981,000 | $1,116,000 | $808,000 | $545,000 |
| Cash Cash Equivalents And Short Term Investments | $23,025,000 | $2,390,000 | $5,355,000 | $1,736,000 |
| Cash And Cash Equivalents | $23,025,000 | $2,390,000 | $5,355,000 | $1,736,000 |
| Debt | ||||
| Total Debt | $14,104,000 | $13,818,000 | $22,340,000 | $10,558,000 |
| Long Term Debt And Capital Lease Obligation | $12,550,000 | $9,141,000 | $1,425,000 | $1,670,000 |
| Long Term Debt | $2,420,000 | - | - | - |
| Current Debt And Capital Lease Obligation | $1,554,000 | $4,677,000 | $20,915,000 | $8,888,000 |
| Current Debt | $149,000 | $3,905,000 | $20,533,000 | $8,549,000 |
| Other Current Borrowings | $149,000 | $3,905,000 | $20,533,000 | $8,549,000 |
| Net Debt | - | $1,515,000 | $15,178,000 | $6,813,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $22,217,000 | $23,671,000 | $29,855,000 | $15,322,000 |
| Total Non Current Liabilities Net Minority Interest | $14,533,000 | $9,413,000 | $3,388,000 | $3,803,000 |
| Other Non Current Liabilities | $1,983,000 | $272,000 | $1,963,000 | $2,010,000 |
| Current Liabilities | $7,684,000 | $14,258,000 | $26,467,000 | $11,519,000 |
| Other Current Liabilities | $452,000 | $1,140,000 | $526,000 | - |
| Current Deferred Liabilities | $492,000 | $1,303,000 | $836,000 | $394,000 |
| Payables And Accrued Expenses | $3,553,000 | $4,620,000 | $2,601,000 | $1,539,000 |
| Payables | $3,167,000 | $4,219,000 | $2,143,000 | $1,376,000 |
| Other Payable | $540,000 | $694,000 | $365,000 | $309,000 |
| Accounts Payable | $2,627,000 | $3,525,000 | $1,778,000 | $1,067,000 |
| Non Current Deferred Liabilities | - | - | - | $2,010,000 |
| Tradeand Other Payables Non Current | - | - | - | - |
| Equity | ||||
| Common Stock Equity | $25,448,000 | $1,330,000 | $-14,853,000 | $-5,929,000 |
| Total Equity Gross Minority Interest | $25,448,000 | $1,330,000 | $-14,853,000 | $-5,929,000 |
| Stockholders Equity | $25,448,000 | $1,330,000 | $-14,853,000 | $-5,929,000 |
| Retained Earnings | $-107,553,000 | $-96,418,000 | $-83,505,000 | $-70,941,000 |
| Other | ||||
| Ordinary Shares Number | $22,666,842 | $17,327,716 | $13,676,804 | $13,163,322 |
| Share Issued | $22,666,842 | $17,327,716 | $13,676,804 | $13,163,322 |
| Tangible Book Value | $25,448,000 | $1,330,000 | $-14,853,000 | $-5,929,000 |
| Invested Capital | $28,017,000 | $5,235,000 | $5,680,000 | $2,620,000 |
| Working Capital | $22,816,000 | $-6,402,000 | $-17,415,000 | $-7,197,000 |
| Capital Lease Obligations | $11,535,000 | $9,913,000 | $1,807,000 | $2,009,000 |
| Total Capitalization | $27,868,000 | $1,330,000 | $-14,853,000 | $-5,929,000 |
| Capital Stock | $133,001,000 | $97,748,000 | $68,652,000 | $65,012,000 |
| Common Stock | $133,001,000 | $97,748,000 | $68,652,000 | $65,012,000 |
| Long Term Capital Lease Obligation | $10,130,000 | $9,141,000 | $1,425,000 | $1,670,000 |
| Current Deferred Revenue | $492,000 | $1,303,000 | $836,000 | $394,000 |
| Current Capital Lease Obligation | $1,405,000 | $772,000 | $382,000 | $339,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $1,528,000 | $1,234,000 | $1,044,000 | $698,000 |
| Current Provisions | $105,000 | $1,284,000 | $545,000 | - |
| Current Accrued Expenses | $386,000 | $401,000 | $458,000 | $163,000 |
| Net PPE | $16,732,000 | $16,774,000 | $5,771,000 | $4,908,000 |
| Accumulated Depreciation | $-2,180,000 | $-2,147,000 | $-1,696,000 | $-2,496,000 |
| Gross PPE | $18,912,000 | $18,921,000 | $7,467,000 | $7,404,000 |
| Leases | $243,000 | $400,000 | $400,000 | $571,000 |
| Other Properties | $830,000 | $890,000 | $830,000 | $3,939,000 |
| Machinery Furniture Equipment | $213,000 | $393,000 | $272,000 | $207,000 |
| Buildings And Improvements | $17,626,000 | $17,238,000 | $5,965,000 | $2,687,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $1,209,000 | $811,000 | $416,000 | $51,000 |
| Work In Process | $2,511,000 | $2,287,000 | $1,626,000 | $1,183,000 |
| Raw Materials | $839,000 | $557,000 | $424,000 | $144,000 |
| Employee Benefits | - | - | $0 | $123,000 |
| Non Current Deferred Revenue | - | - | - | $2,010,000 |
Fetched: 2026-06-16
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-9,581,000 | $-9,519,000 | $-9,996,000 | $-10,497,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-7,226,000 | $-6,684,000 | $-8,522,000 | $-9,241,000 |
| Cash Flow From Continuing Operating Activities | $-7,226,000 | $-6,684,000 | $-8,522,000 | $-9,241,000 |
| Operating Gains Losses | - | $3,911,000 | $1,550,000 | $261,000 |
| Investing Activities | ||||
| Capital Expenditure | $-2,355,000 | $-2,835,000 | $-1,474,000 | $-1,256,000 |
| Investing Cash Flow | $-2,365,000 | $-3,027,000 | $-1,474,000 | $-1,256,000 |
| Cash Flow From Continuing Investing Activities | $-2,365,000 | $-3,027,000 | $-1,474,000 | $-1,256,000 |
| Net Other Investing Changes | $-10,000 | $-192,000 | - | - |
| Financing Activities | ||||
| Issuance Of Capital Stock | $18,262,000 | $4,330,000 | $0 | $0 |
| Financing Cash Flow | $30,187,000 | $6,780,000 | $13,556,000 | $8,138,000 |
| Cash Flow From Continuing Financing Activities | $30,187,000 | $6,780,000 | $13,556,000 | $8,138,000 |
| Net Other Financing Charges | $-159,000 | - | - | $-38,000 |
| Net Common Stock Issuance | $18,262,000 | $4,330,000 | $0 | $0 |
| Common Stock Issuance | $18,262,000 | $4,330,000 | $0 | $0 |
| Other | ||||
| Repayment Of Debt | $-7,154,000 | $-1,375,000 | $-364,000 | $-359,000 |
| Issuance Of Debt | $12,402,000 | $3,417,000 | $13,517,000 | $7,658,000 |
| End Cash Position | $23,025,000 | $2,390,000 | $5,355,000 | $1,736,000 |
| Beginning Cash Position | $2,390,000 | $5,355,000 | $1,736,000 | $4,117,000 |
| Effect Of Exchange Rate Changes | $39,000 | $-34,000 | $59,000 | $-22,000 |
| Changes In Cash | $20,596,000 | $-2,931,000 | $3,560,000 | $-2,359,000 |
| Proceeds From Stock Option Exercised | $6,836,000 | $408,000 | $403,000 | $877,000 |
| Net Issuance Payments Of Debt | $5,248,000 | $2,042,000 | $13,153,000 | $7,299,000 |
| Net Long Term Debt Issuance | $5,248,000 | $2,042,000 | $-364,000 | $7,299,000 |
| Long Term Debt Payments | $-7,154,000 | $-1,375,000 | $-364,000 | $-359,000 |
| Long Term Debt Issuance | $12,402,000 | $3,417,000 | $13,517,000 | $7,658,000 |
| Net PPE Purchase And Sale | $-2,355,000 | $-2,835,000 | $-1,474,000 | $-1,256,000 |
| Purchase Of PPE | $-2,355,000 | $-2,835,000 | $-1,474,000 | $-1,256,000 |
| Change In Working Capital | $-1,942,000 | $-555,000 | $755,000 | $-308,000 |
| Change In Other Working Capital | $-415,000 | $188,000 | $354,000 | - |
| Change In Payables And Accrued Expense | $482,000 | $1,040,000 | $1,511,000 | $730,000 |
| Change In Inventory | $-904,000 | $-1,189,000 | $-1,088,000 | $-450,000 |
| Change In Receivables | $-1,105,000 | $-594,000 | $-22,000 | $-588,000 |
| Changes In Account Receivables | $-865,000 | $-308,000 | $-262,000 | $-159,000 |
| Other Non Cash Items | $3,630,000 | $1,021,000 | $866,000 | $119,000 |
| Stock Based Compensation | $597,000 | $601,000 | $563,000 | $1,352,000 |
| Depreciation Amortization Depletion | $1,624,000 | $1,251,000 | $840,000 | $712,000 |
| Depreciation And Amortization | $1,624,000 | $1,251,000 | $840,000 | $712,000 |
| Net Income From Continuing Operations | $-11,135,000 | $-12,913,000 | $-12,564,000 | $-11,236,000 |
| Net Short Term Debt Issuance | - | $3,314,000 | $13,517,000 | - |
| Short Term Debt Issuance | - | $3,314,000 | $13,517,000 | - |
| Interest Paid Cfo | - | $0 | $-532,000 | $-141,000 |
| Depreciation | - | $1,251,000 | $840,000 | - |
| Gain Loss On Investment Securities | - | $3,911,000 | $1,550,000 | $261,000 |
| Short Term Debt Payments | - | - | - | - |
Fetched: 2026-06-16